APA (7th ed.) Citation

Salgado, M., de la Camara-Gómez, J., García-Escobar, I., Álvarez-Llosa, R., González-Villarroel, P., Garay, D. F., . . . Querol, R. (2025). Tinzaparin for the prevention of thromboembolic events in ambulatory patients with metastatic colorectal cancer receiving first line treatment: A randomised, clinical trial design. BMC Cancer, 25(1), 1. https://doi.org/10.1186/s12885-025-14620-z

Chicago Style (17th ed.) Citation

Salgado, Mercedes, et al. "Tinzaparin for the Prevention of Thromboembolic Events in Ambulatory Patients with Metastatic Colorectal Cancer Receiving First Line Treatment: A Randomised, Clinical Trial Design." BMC Cancer 25, no. 1 (2025): 1. https://doi.org/10.1186/s12885-025-14620-z.

MLA (9th ed.) Citation

Salgado, Mercedes, et al. "Tinzaparin for the Prevention of Thromboembolic Events in Ambulatory Patients with Metastatic Colorectal Cancer Receiving First Line Treatment: A Randomised, Clinical Trial Design." BMC Cancer, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12885-025-14620-z.